Capricor Therapeutics, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 14 →InsidersNo open-market buys. 3 insiders sold $6.9M, 7 of 9 sales on a 10b5-1 plan.→HoldersBlackRock 7.1%Tang 7.1%Montanova Capital 7.0%→Financing →PeersClosest companies: IOVA, SRPT, NTLA→
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- −$129.4Mlast 12 months
- Operating cash flow
- −$92.6Mlast 12 months
- Cash and equivalents
- $20.9Mat the last balance sheet
- Shares outstanding
- 58.1M shareson issue